Related Experiment Video

Updated: Jun 24, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Neonatal hyperbilirubinemia and early discharge from the maternity ward

Daniele De Luca1, Virgilio P Carnielli, Piermichele Paolillo

  • 1Division of Neonatology, Casilino General Hospital, ASL RM-B, Rome, Italy. dm.deluca@fastwebnet.it

European Journal of Pediatrics
|March 12, 2009
PubMed

Insights

Early hospital discharge for newborns can complicate jaundice management. However, reliable prediction tools and planned follow-up enable safe early discharge, preventing newborn rehospitalization due to hyperbilirubinemia.

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Public Health

Background:

  • Early discharge from maternity hospitals is increasingly common.
  • Hyperbilirubinemia (jaundice) is a frequent cause of newborn rehospitalization.
  • Current practices may pose challenges for effective jaundice management in early-discharged infants.

Purpose of the Study:

  • To review guidelines for jaundice management and early discharge.
  • To provide an evidence-based update on predictive tools for neonatal jaundice.
  • To offer practical advice for safe early discharge and follow-up protocols.

Main Methods:

  • Review of existing guidelines for neonatal jaundice and early discharge.
  • Analysis of evidence on predictive factors for hyperbilirubinemia.
  • Development of a practical flowchart for jaundice risk assessment and management.

Main Results:

  • Gestational age, nomogram evaluation, two-point bilirubin assay, and rate of rise are key predictors.
  • Identifying the appropriate bilirubin nomogram curve is crucial.
  • Unforeseen risk factors for jaundice require careful consideration.
  • Predictive tools can reliably forecast jaundice risk.

Conclusions:

  • Available predictive tools enable reliable jaundice prediction.
  • Safe early discharge is achievable with adequate, prediction-based follow-up.
  • Implementing evidence-based protocols can mitigate risks associated with early discharge and jaundice.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...